Eosinophilic arthritis

Rheumatology

Volumn 38, Issue 12, 1999, Pages 1188-1194

  Tay, C H ^a  

^a MOUNT ELIZABETH MEDICAL CENTRE   (Singapore)

Author keywords

Diethylcarbamazine citrate; Eosinophilic arthritis; Hypereosinophilia; Idiopathic hypereosinophilic syndrome; Levamisole

Indexed keywords

ANTHELMINTIC AGENT; CORTICOSTEROID; DIETHYLCARBAMAZINE; LEVAMISOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE;

ADULT; ANKLE; ARTICLE; CLINICAL ARTICLE; ELBOW; EOSINOPHIL; FEMALE; HUMAN; HYPEREOSINOPHILIA; KNEE; MALE; ORAL DRUG ADMINISTRATION; POLYARTHRITIS; PRIORITY JOURNAL; SHOULDER; TREATMENT OUTCOME; URTICARIA;

EID: 0032761645     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.12.1188     Document Type: Article

References (27)

1. Spry CJE. Eosinophils- a guide to the scientific and medical literature. Oxford: Oxford University Press, 1988.
2. Ritchie DM, Boyle JA, Mclnnes JM et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968;37:393-406.
3. Rothen ME. Eosinophilia - mechanisms of disease. N Engl J Med 1998;339:1592-600.
4. Capron M. Eosinophils and parasites. Ann Parasitol Hum Comp 1991;66(suppl.):41-5.
5. Kaufman LD, Kephart GM, Seidman RJ et al. The spectrum of eosinophilic myositis. Arthritis Rheum 1993; 36:1014-24.
6. Shulman LE. Diffuse fasciitis with eosinophilia: a new syndrome. Arthritis Rheum 1977;29:S205-15.
7. Silver RM. Eosinophilia-myalgia syndrome, toxic oil syndrome and diffuse fasciitis with eosinophilia. Curr Opin Rheumatol 1992;4:851-6.
8. Snyman JR, Sommers DK, Gregorowski MD et al. Effect of cetirizine, ketotifen and chlorpheniramine on dynamics of the cutaneous hypersensitivity reaction: a comparative study. Eur J Clin Pharmacol 1992;42:359-62.
9. Danaraj TJ, Pacheco G, Shanmugaratnam K et al. Tropical eosinophilia. Am J Trop Med Hyg 1966;15:183-6.
10. Wilcoks C, Manson-Bahr PEC. Manson's tropical diseases - filariasis. London: The Whitefriars Press, 1972.
11. Mahmound AAF. Strongyloidiasis. Clin Infect Dis 1996;36:949-1055.
12. Hardy WR, Anderson RE. The hypereosinophilic syndrome. Ann Intern Med 1968;68:1220-9.
13. Weller PF, Bubley GJ. The idiopathic eosinophilic syndrome. Blood 1994;83:2759-79.
14. Brogadir SP, Goldwein MI, Schumacher HR. A hypereosinophilic syndrome mimicking rheumatoid arthritis. Am J Med 1980;69:799-80.
15. Marin-Santos JM, Mulero J, Andreu JL et al. Arthritis in idiopathic hypereosinophilic syndrome. Arthritis Rheum 1988;31:120-5.
16. Anders HJ, Schattenkirchner M. Destructive joint lesions and bursitis in idiopathic hypereosinophilic syndrome. Rheumatology 1999;38:185-6.
17. Schlegel SI, Paulus HE. Nonsteroidal antiinflammatory drugs - use in rheumatic diseases, side effects and interactions. Bull Rheum Dis 1986;36:1-8.
18. Schleimer PR, Bochner BS. The effects of glucocorticoids on human eosinophils. J Allergy Clin Immunol 1994; 94:1202-13.
19. Adcock IM, Lane SJ, Brown CR et al. Abnormal glucocorticoid receptor-activator Protein 1 interaction in steroid-resistant asthma. J Exp Med 1995;182:1951-8.
20. Parrillo JE, Fauci AS, Wolff SM. Therapy of hypereosinophilic syndrome. Ann Intern Med 1978;89:167-72.
21. Aldebert D, Lamkhioued B, Desaint C et al. Eosinophils express a functional receptor for interferon alpha. Blood 1996;87:2354-60.
22. Morley J. Cyclosporin A in asthma therapy: a pharmacological rationale. J Autoimmun 1992;5(suppl. A):265-9.
23. Wegner CD, Gundel RH, Relly P et al. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990;247:456-9.
24. Dent G, Giembycz MA. Phosphodiesterase inhibitors: Lily in the Pink's medicinal compound for asthma? Thorax 1996;51:647-9.
25. Huskisson EC, Dieppe PA, Scott J et al. Immunostimulant therapy with levamisole for rheumatoid arthritis. Lancet 1976;1:151-6.
26. Islam N, Karim AKMB, Rahman K.M. Eosinophilic leukaemia. Postgrad Med J 1972;48:442-5.
27. Yam LT, Li CY, Necheles TF et al. Pseudoeosinophilic endocarditis and eosinophilic leukaemia. Am J Med 1972;5:193-202.